CIK 0001609809 · Non-accelerated filer<br>Smaller reporting company
Seres Therapeutics, Inc.
Sign in to watch- Ticker
- MCRB
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 274326290
- Phone
- 617 945 9626
- Business address
- 200 SIDNEY STREET, CAMBRIDGE, MA, 02139
- Former names
- Seres Therapeutics, Inc., Seres Health, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $2,230
- in 4 filings, $2K under 10b5-1 plans
Net −$2,230. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-11-18 | Henn Matthew R. See Remarks | Sale 10b5-1 | −927 | $0.54 | $501 | 77,770 |
| 2024-11-18 | Shaff Eric D. CEO and President | Sale 10b5-1 | −2,505 | $0.54 | $1K | 170,389 |
| 2024-11-15 | DesRosier Thomas Chief Legal Officer and EVP | Option exercise 10b5-1 | +2,656 | 136,070 | ||
| 2024-11-15 | DesRosier Thomas Chief Legal Officer and EVP | Option exercise · Restricted Stock Units 10b5-1 | −2,656 | 23,907 | ||
| 2024-11-15 | von Moltke Lisa See Remarks | Option exercise 10b5-1 | +2,969 | 33,392 | ||
| 2024-11-15 | von Moltke Lisa See Remarks | Option exercise · Restricted Stock Units 10b5-1 | −2,969 | 26,719 | ||
| 2024-11-15 | Young Teresa L. See Remarks | Option exercise 10b5-1 | +2,656 | 91,139 | ||
| 2024-11-15 | Young Teresa L. See Remarks | Option exercise · Restricted Stock Units 10b5-1 | −2,656 | 23,907 | ||
| 2024-11-15 | Henn Matthew R. See Remarks | Option exercise 10b5-1 | +2,812 | 78,697 | ||
| 2024-11-15 | Henn Matthew R. See Remarks | Option exercise · Restricted Stock Units 10b5-1 | −2,812 | 25,313 | ||
| 2024-11-15 | Shaff Eric D. CEO and President | Option exercise 10b5-1 | +7,812 | 172,894 | ||
| 2024-11-15 | Shaff Eric D. CEO and President | Option exercise · Restricted Stock Units 10b5-1 | −7,812 | 70,313 | ||
| 2024-10-28 | von Moltke Lisa See Remarks | Sale 10b5-1 | −4,334 | $0.69 | $3K | 30,423 |
| 2024-10-28 | Henn Matthew R. See Remarks | Sale 10b5-1 | −3,984 | $0.69 | $3K | 75,885 |
| 2024-10-28 | DesRosier Thomas Chief Legal Officer and EVP | Sale 10b5-1 | −4,259 | $0.69 | $3K | 133,414 |
| 2024-10-28 | Shaff Eric D. CEO and President | Sale 10b5-1 | −8,748 | $0.69 | $6K | 165,082 |
| 2024-10-28 | Young Teresa L. See Remarks | Sale 10b5-1 | −2,983 | $0.69 | $2K | 88,483 |
| 2024-10-27 | von Moltke Lisa See Remarks | Option exercise 10b5-1 | +13,744 | 34,757 | ||
| 2024-10-27 | von Moltke Lisa See Remarks | Option exercise · Restricted Stock Units 10b5-1 | −13,744 | 0 | ||
| 2024-10-27 | Henn Matthew R. See Remarks | Option exercise 10b5-1 | +12,622 | 79,869 |
Page 10 of 13 · 254 trades